In-Vitro Diagnostic Substance Manufacturing - Market Size, Financial Statistics, Industry Trends
Industry Overview
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.Source: U.S. Census Bureau
In-Vitro Diagnostic Substance Manufacturing Market Size
This report includes historical and forecasted market sizes and industry trends for In-Vitro Diagnostic Substance Manufacturing. It reveals overall market dynamics from 2020 through the present, and predicts industry growth or shrinkage through 2030. Revenue data include both public and private companies in the In-Vitro Diagnostic Substance Manufacturing industry.| Historical | Forecasted | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | |
| Market Size (Total Revenue) | Included in Report |
||||||||||
| % Growth Rate | |||||||||||
| Number of Companies | |||||||||||
| Total Employees | |||||||||||
| Average Revenue per Company | |||||||||||
| Average Employees per Company | |||||||||||
Industry Revenue ($ Billions)
Industry Forecast ($ Billions)
Pell Research's advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size statistics include revenue generated from all products and services sold within the In-Vitro Diagnostic Substance Manufacturing industry.
Geographic Breakdown by U.S. State
In-Vitro Diagnostic Substance Manufacturing market share by state pinpoints local opportunities based on regional revenue statistics. Growth rate for each state is affected by regional economic conditions. Data by state can be used to locate profitable and nonprofitable locations for In-Vitro Diagnostic Substance Manufacturing companies in the United States.Industry Revenue by State [Sample]
Distribution by Company Size
| Company Size | All Industries | In-Vitro Diagnostic Substance Manufacturing |
|---|---|---|
| Small Business (< 5 Employees) | Included |
|
| Small Business (5 - 20) | ||
| Midsized Business (20 - 100) | ||
| Large Business (100 - 500) | ||
| Enterprise (> 500) | ||
Industry Income Statement (Average Financial Metrics)
Financial statement analysis determines averages for the following industry forces:- Cost of goods sold
- Compensation of officers
- Salaries and wages
- Employee benefit programs
- Rent paid
- Advertising and marketing budgets
The report includes a traditional income statement from an "average" In-Vitro Diagnostic Substance Manufacturing company (both public and private companies are included).
| Industry Average | Percent of Sales | |
|---|---|---|
| Total Revenue | Included |
|
| Operating Revenue | ||
| Cost of Goods Sold (COGS) | ||
| Gross Profit | ||
| Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| Earnings Before Interest and Taxes (EBIT) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit | ||
Average Income Statement
Cost of Goods Sold
Salaries, Wages, and Benefits
Rent
Advertising
Depreciation and Amortization
Officer Compensation
Net Income
Financial Ratio Analysis
Financial ratios allow a company's performance to be compared against that of its peers.| Financial Ratio | Industry Average |
|---|---|
| Profitability Ratios | Included |
| Profit Margin | |
| ROE | |
| ROA | |
| Liquidity Ratios | |
| Current Ratio | |
| Quick Ratio | |
| Activity Ratios | |
| Average Collection Period | |
| Asset Turnover Ratio | |
| Receivables Turnover Ratio | |
| Inventory Conversion Ratio |
Products and Services Mix
Product lines and services in the In-Vitro Diagnostic Substance Manufacturing industry accounting for the largest revenue sources.| Product Description | Description | Revenue ($ Millions) |
|
|---|---|---|---|
In-vitro diagnostic substance manufacturing |
Included |
||
In-vitro diagnostic substances |
|||
In vitro diagnostic substances, nsk, total |
|||
In vitro diagnostic substances, nsk, administrative-records |
|||
Compensation and Salary Surveys
Salary information for employees working in the In-Vitro Diagnostic Substance Manufacturing industry.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 11% |
Included |
||
| Chief Executives | 0% | |||
| General and Operations Managers | 2% | |||
| Business and Financial Operations Occupations | 8% | |||
| Business Operations Specialists | 7% | |||
| Architecture and Engineering Occupations | 6% | |||
| Life, Physical, and Social Science Occupations | 16% | |||
| Life Scientists | 6% | |||
| Physical Scientists | 6% | |||
| Chemists and Materials Scientists | 6% | |||
| Chemists | 6% | |||
| Office and Administrative Support Occupations | 8% | |||
| Production Occupations | 32% | |||
| Other Production Occupations | 26% | |||
| Packaging and Filling Machine Operators and Tenders | 9% | |||
| Packaging and Filling Machine Operators and Tenders | 9% | |||
Government Contracts
The federal government spent an annual total of $184,699,470 on the In-Vitro Diagnostic Substance Manufacturing industry. It has awarded 4,677 contracts to 256 companies, with an average value of $721,482 per company.Top Companies in In-Vitro Diagnostic Substance Manufacturing and Adjacent Industries
| Company | Address | Revenue ($ Millions) |
|---|---|---|
Included |
||